|
HIV/AIDS
Citations 111-120 of 125 total displayed.
|
Past content
(since Feb 1998):
|
- Clinical Observations
Life-Threatening Interactions Between HIV-1 Protease Inhibitors and the Illicit Drugs MDMA and  -Hydroxybutyrate
- Robert D. Harrington; Jane A. Woodward; Thomas M. Hooton; John R. Horn
Arch Intern Med 1999; 159: 2221-2224.
[Abstract]
[Full text]
[PDF]
- Review Articles
Think HIV: Why Physicians Should Lower Their Threshold for HIV Testing
- Kenneth A. Freedberg; Jeffrey H. Samet
Arch Intern Med 1999; 159: 1994-2000.
[Extract]
[Full text]
[PDF]
- Original Investigations
Human Immunodeficiency Virus 1 Protease Inhibitors in Clinical Practice: Predictors of Virological Outcome
- Hernan Valdez; Michael M. Lederman; Ian Woolley; Courtney J. Walker; Lance T. Vernon; Amy Hise; Barbara M. Gripshover
Arch Intern Med 1999; 159: 1771-1776.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Enteric Infections and Diarrhea in Human Immunodeficiency Virus–Infected Persons: Prospective Community-Based Cohort Study
- Rainer Weber; Bruno Ledergerber; Reinhard Zbinden; Martin Altwegg; Gaby E. Pfyffer; Max A. Spycher; Jakob Briner; Laurent Kaiser; Milos Opravil; Christa Meyenberger; Markus Flepp; for the Swiss HIV Cohort Study
Arch Intern Med 1999; 159: 1473-1480.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Increased Incidence of Infectious Diseases During Prospective Follow-up of Human T-Lymphotropic Virus Type II– and I–Infected Blood Donors
- Edward L. Murphy; Simone A. Glynn; Joy Fridey; James W. Smith; Ronald A. Sacher; Catharie C. Nass; Helen E. Ownby; David J. Wright; George J. Nemo; for the Retrovirus Epidemiology Donor Study
Arch Intern Med 1999; 159: 1485-1491.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Why Is HIV Rarely Transmitted by Oral Secretions?: Saliva Can Disrupt Orally Shed, Infected Leukocytes
- Samuel Baron; Joyce Poast; Miles W. Cloyd
Arch Intern Med 1999; 159: 303-310.
[Abstract]
[Full text]
[PDF]
- Original Investigations
A New Model of Advance Care Planning: Observations From People With HIV
- Douglas K. Martin; Elaine C. Thiel; Peter A. Singer
Arch Intern Med 1999; 159: 86-92.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Patterns of Use, Expenditures, and Perceived Efficacy of Complementary and Alternative Therapies in HIV-Infected Patients
- Kathleen M. Fairfield; David M. Eisenberg; Roger B. Davis; Howard Libman; Russell S. Phillips
Arch Intern Med 1998; 158: 2257-2264.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Preventive Therapy for Tuberculosis in HIV-Infected Persons: Analysis of Policy Options Based on Tuberculin Status and CD4+Cell Count
- Holger Sawert; Enrico Girardi; Giorgio Antonucci; Mario C. Raviglione; Pierluigi Viale; Giuseppe Ippolito; for the Gruppo Italiano di Studio Tubercolosi e AIDS
Arch Intern Med 1998; 158: 2112-2121.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Influence of Human Immunodeficiency Virus 1 Infection and Degree of Immunosuppression in the Clinical Characteristics and Outcome of Infective Endocarditis in Intravenous Drug Users
- Esteban Ribera; José M. Miró; Emilia Cortés; Ana Cruceta; Jordi Merce; Francesc Marco; Ana Planes; Joan Carles Paré; Asunción Moreno; Imma Ocaña; José M. Gatell; Albert Pahissa
Arch Intern Med 1998; 158: 2043-2050.
[Abstract]
[Full text]
[PDF]
|
|
